These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9534197)

  • 1. Investigators involved in toremifene studies call it a potentially safer antiestrogen.
    Oncology (Williston Park); 1998 Mar; 12(3):469. PubMed ID: 9534197
    [No Abstract]   [Full Text] [Related]  

  • 2. Re: In search of the perfect SERM: beyond tamoxifen and raloxifene.
    Williams GM
    J Natl Cancer Inst; 1998 Nov; 90(21):1671. PubMed ID: 9811319
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiestrogen therapy: uncertainties and risk assessment.
    Smith LL; White IN
    Oncology (Williston Park); 1998 Mar; 12(3 Suppl 5):14-22. PubMed ID: 9556786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression changes during the development of estrogen-independent and antiestrogen-resistant growth in breast cancer cell culture models.
    Pennanen PT; Sarvilinna NS; Ylikomi TJ
    Anticancer Drugs; 2009 Jan; 20(1):51-8. PubMed ID: 19343000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety assessment of tamoxifen and toremifene.
    Williams GM; Jeffrey AM
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):41-7. PubMed ID: 9165506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The in vitro combination-effect of toremifene with CAF (cyclophosphamide, adriamycin, 5-fluorouracil) on growth of various human mammary carcinomas].
    Kuroiwa S; Maruyama S; Okada M; Abe F
    Gan To Kagaku Ryoho; 1998 Aug; 25(10):1581-9. PubMed ID: 9725052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiestrogen stimulated human endometrial cancer growth: laboratory and clinical considerations.
    Tonetti DA; O'Regan R; Tanjore S; England G; Jordan VC
    J Steroid Biochem Mol Biol; 1998 Apr; 65(1-6):181-9. PubMed ID: 9699872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toremifene citrate (Fareston).
    Gerken P
    Clin J Oncol Nurs; 2004 Oct; 8(5):529-30. PubMed ID: 15565747
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of toremifene on the expression of genes in a rat mammary adenocarcinoma.
    Kellen JA; Mirakian A
    In Vivo; 1996; 10(5):511-3. PubMed ID: 8899431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiestrogen therapy for breast cancer: current strategies and future prospects.
    Jordan VC; Tormey DC
    Cancer Treat Res; 1988; 39():97-110. PubMed ID: 2908611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison between the effects of tamoxifen and toremifene on the uterus in postmenopausal breast cancer patients.
    Tomás E; Kauppila A; Blanco G; Apaja-Sarkkinen M; Laatikainen T
    Gynecol Oncol; 1995 Nov; 59(2):261-6. PubMed ID: 7590484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reliability of estrogen receptors in predicting response to antiestrogens.
    Valavaara R
    Oncology (Williston Park); 1997 May; 11(5 Suppl 4):14-8. PubMed ID: 9165501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toremifene and letrozole for advanced breast cancer.
    Med Lett Drugs Ther; 1998 Apr; 40(1024):43-5. PubMed ID: 9580744
    [No Abstract]   [Full Text] [Related]  

  • 14. Inhibitory effects of an antiestrogen, toremifene, on the phorbol ester-induced adhesive capacity of breast carcinoma cells.
    Maemura M; Iino Y; Horiguchi J; Takei H; Horii Y; Koibuchi Y; Yokoe T; Takeyoshi I; Ohwada S; Morishita Y
    Int J Oncol; 1998 Nov; 13(5):981-5. PubMed ID: 9772290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Toremifene sensitized the effect of adriamycin on human breast cancer cell lines].
    Nakagomi H; Furuya K; Hagiwara J; Nishio T; Watanabe K; Muto S; Takano K; Tada Y
    Gan To Kagaku Ryoho; 1998 Apr; 25 Suppl 3():454-8. PubMed ID: 9589052
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antitumour effect of a combination of toremifene and interferon-alpha on ZR-75-1 human breast cancer cells: dependence on interferon-alpha subtype.
    Martin JH; Symonds A
    Oncol Rep; 2002; 9(2):379-82. PubMed ID: 11836612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive and synergistic effects of a novel antiestrogen, toremifene (Fc-1157a), and human interferons on estrogen responsive MCF-7 cells in vitro.
    Kangas L; Nieminen AL; Cantell K
    Med Biol; 1985; 63(4):187-90. PubMed ID: 2419713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prospective study on gynaecological effects of two antioestrogens tamoxifen and toremifene in postmenopausal women.
    Marttunen MB; Cacciatore B; Hietanen P; Pyrhönen S; Tiitinen A; Wahlström T; Ylikorkala O
    Br J Cancer; 2001 Apr; 84(7):897-902. PubMed ID: 11286468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogens and women with breast cancer.
    Tartter PI
    Oncology (Williston Park); 1998 May; 12(5):638, 643. PubMed ID: 9597675
    [No Abstract]   [Full Text] [Related]  

  • 20. Prospective evaluation of estrogen receptor-beta in predicting response to neoadjuvant antiestrogen therapy in elderly breast cancer patients.
    Cappelletti V; Celio L; Bajetta E; Allevi A; Longarini R; Miodini P; Villa R; Fabbri A; Mariani L; Giovanazzi R; Galante E; Greco M; Grazia Daidone M
    Endocr Relat Cancer; 2004 Dec; 11(4):761-70. PubMed ID: 15613450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.